Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Submicroscopic malaria in pregnancy and associated adverse pregnancy events: A case-cohort study of 4,352 women on the Thailand–Myanmar border
Gilder ME. et al, (2025), PLOS Medicine, 22, e1004529 - e1004529
Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers.
Watson JA. et al, (2025), Antimicrob Agents Chemother
Dose‐Optimization of a Novel Co‐Formulated Triple Combination Antimalarial Therapy: Artemether‐Lumefantrine‐Amodiaquine
Tarning J. et al, (2025), Clinical Pharmacology & Therapeutics
A comparison of national seasonal influenza treatment guidelines across the Asia Pacific region.
Beer E. et al, (2025), PLOS global public health, 5
Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background
Nayak S. et al, (2024), Nature Communications, 15
In‐host modeling of dengue virus and non‐structural protein 1 and the effects of ivermectin in patients with acute dengue fever
Ding J. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology, 13, 2196 - 2209
Evidence that remdesivir treatment reduces viral titers in patients with COVID-19.
Boyd S. et al, (2024), Antimicrobial agents and chemotherapy
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis
Commons RJ. et al, (2024), The Lancet Child & Adolescent Health, 8, 798 - 808
Author Correction: Ivermectin metabolites reduce Anopheles survival.
Kobylinski KC. et al, (2024), Scientific reports, 14
Rectal artesunate: lives not saved
White NJ. et al, (2024), Transactions of The Royal Society of Tropical Medicine and Hygiene, 118, 639 - 641
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers.
Tarning J. et al, (2024), Malaria journal, 23
Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis
Fadilah I. et al, (2024), PLOS Medicine, 21, e1004411 - e1004411
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS medicine, 21
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
Wongnak P. et al, (2024), The Lancet Infectious Diseases, 24, 953 - 963
SEVUparin as a potential Adjunctive Treatment in children with severe malaria: A phase I trial safety and dose finding trial (SEVUSMAART)
Maitland K. et al, (2024), Wellcome Open Research, 8, 484 - 484
Lineage-informative microhaplotypes for recurrence classification and spatio-temporal surveillance of Plasmodium vivax malaria parasites
Siegel SV. et al, (2024), Nature Communications, 15
Artemisinin-resistant malaria in Africa demands urgent action
Dhorda M. et al, (2024), Science, 385, 252 - 254